Stevanato Group Stock Fair Value Calculation – Stevanato Group Reiterates Guidance, Sees Supportive Revenue Growth

☀️Trending News

The Stevanato Group ($NYSE:STVN) is a leading international manufacturer of specialty glass and plastic components for the pharmaceutical and biomedical industries. With the reiteration of its guidance and supportive revenue growth, the company has proven itself to be a reliable and secure investment for shareholders. Its portfolio also includes the production of medical device components, as well as the packaging and filling of injectable drug products. The company also has a strong commitment to research and development, as evidenced by its investments in new product launches and technological innovations.

With an experienced management team, the company has achieved impressive results in recent years, including record-breaking sales and profits. It is this track record of success that has enabled the company to reiterate its guidance and experience supportive revenue growth. This commitment to innovation and growth is expected to continue into 2021 and beyond, providing shareholders with an attractive opportunity for long-term capital appreciation.

Earnings

In its FY2023 Q3 earning report ending September 30 2021, STEVANATO GROUP reported a total revenue of 214.54M EUR and net income of 18.66M EUR. This represents a 12.5% decrease in total revenue and 48.5% decrease in net income compared to the same period last year. However, over the last 3 years, STEVANATO GROUP’s total revenue has increased from 214.54M EUR to 271.4M EUR. Despite the decrease in this quarter, the Group remains confident that its revenue growth will remain supportive in the long run.

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Stevanato Group. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Stevanato Group. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Stevanato Group. More…

Key Ratios Snapshot

Some of the financial key ratios for Stevanato Group are shown below. More…

Stock Price

On Wednesday, STEVANATO GROUP reaffirmed its guidance for the 2021 fiscal year with a share price of $27.3 at opening and a close of $27.8, an increase of 3.3% from the previous day’s close. The company sees the current market conditions as supportive of revenue growth, with a strong outlook for the coming year. The company’s focus on innovation, expansion, and technology enables them to stay ahead of the competition in terms of both market share and profitability. They are also leveraging insights from customer behaviour and analytics to drive new customer acquisition and loyalty. STEVANATO GROUP is confident that these strategies will continue to provide them with a competitive edge and support their growth going forward.

These positive outlooks have been further buoyed by a strengthening global economy, which should ensure that the company’s current momentum is maintained for the foreseeable future. The company’s leading position in the market has already resulted in significant growth and creates an optimistic outlook for the future. Given the promising outlook, STEVANATO GROUP is confident that their guidance will be met or exceeded in 2021. The company is well positioned to capitalize on future growth opportunities and continue to deliver results for its shareholders. Live Quote…

Analysis – Stevanato Group Stock Fair Value Calculation

At GoodWhale, we recently conducted an analysis of STEVANATO GROUP‘s wellbeing. We used our proprietary Valuation Line to determine that the intrinsic value of STEVANATO GROUP’s shares is around $24.1. Currently, STEVANATO GROUP’s stock is traded at $27.8, meaning the price is overvalued by 15.3%. Our analysis indicates that the fair price of STEVANATO GROUP stock is $24.1. More…

Peers

The company has a long history of success and has a strong market presence in Europe, North America, and Asia. Its main competitors are One Glove Group Bhd, Essilorluxottica, and Ansell Ltd.

– One Glove Group Bhd ($KLSE:5079)

One Glove Group Bhd is a Malaysian company that manufactures and sells gloves. The company has a market capitalization of 133.48 million as of 2022 and a return on equity of -17.63%. One Glove Group Bhd is involved in the production of latex, nitrile, and vinyl gloves. The company also provides gloves for the food, healthcare, and industrial sectors.

– Essilorluxottica ($OTCPK:ESLOY)

With a market capitalization of 78.25 billion as of 2022 and a return on equity of 4.79%, EssilorLuxottica is a French-Italian multinational corporation that designs, manufactures, and markets ophthalmic lenses, optical frames, sunglasses, contact lenses, and prescription eyewear. The company also provides eye care services. EssilorLuxottica is headquartered in Paris, France.

– Ansell Ltd ($ASX:ANN)

Ansell Ltd is a publicly traded company with a market capitalization of 3.53 billion as of 2022. The company has a return on equity of 9.21%. Ansell is a global leader in providing protective solutions. The company designs, develops, manufactures, and markets a variety of protection solutions, including gloves, clothing, and other products.

Summary

Stevanato Group is a global leader in the pharmaceutical industry, providing innovative solutions for drug delivery systems. The company’s stock has been steadily increasing, with a strong showing over the past year. This could be attributed to a number of factors, including a focus on guidance reiterated and supportive revenue growth. Furthermore, the company recently announced the launch of a new platform that looks to revolutionize pharmaceutical packaging.

This could be a major boon to the company, helping to drive further growth in the future. The combination of guidance reiterated from management and potential for new products to drive revenue make Stevanato Group a strong investment option for investors looking for long-term returns.